Alexandre Corrêa

Experience

• 

  Darrow Laboratórios SA

  Sept 1999 - Mar 2004

  Financial Coordinator

  Management of 6 employees distributed across the following areas:Treasury, accounts receivable, accounts payable, cash collection, cash flow management and costs.• Analysis of budget versus actual reports and Company Results in terms of expenses, investments, sales, break-even point, cash flow and trial balance.• New products pricing and price readjustment policy.• Investments’ Economical Feasibility studies.• Management of direct and indirect industrial costs for comparison reports of the real cost versus standard.• Negotiation of Production outsourcing contracts.• Participation as coordinator for ERP- JD Edwards implementation.• Brazil’s monthly management reports. Information Analysis, KPI’s monitoring and Variations Highlighting with recommend corrective actions by Business Line.• Investments projections for a new plant and Industrial automation (Total amount of BRL 9.000.000,00).• Member of the Company Production Optimization Team. Show less

• 

  Bureau Veritas Group

  Mar 2004 - Jun 2006

  Regional CFO

  Management of 33 employees distributed across the 4 countries and the following areas:Business Planning, Accounting, Tax, Treasury, accounts receivable, accounts payable, cash collection, HR, IT, Purchase and Intercompany Operations.• Reengineering of Brazil Finance Organization of Andean Pact.• Responsible of the Financial Shared Service Center implementation.• Brazil’s monthly management reports. Information Analysis, KPI’s monitoring and Variations Highlighting with recommend corrective actions by Business Line.• Responsible of the Risk Management and the Ethic Code implementation.• Responsible of the balance sheet conversion to IFRS for the Group consolidation. Show less

• 

  Pierre Fabre Group

  Jun 2006 - Sept 2010

  CFO Brasil

  Management of 30 employees distributed across the following areas:Business Planning, Accounting, Tax, Treasury, accounts receivable, accounts payable, cash collection, Invoicing, Logistics, HR, IT, Purchase and Intercompany Operations.• Responsible of the Financial Shared Service Center implementation.• Brazil’s monthly management reports. Information Analysis, KPI’s monitoring and Variations Highlighting with recommend corrective actions by Business Line.• Participation for the Due Diligence of Darrow Laboratórios Acquisition.• Responsible of the balance sheet conversion to IFRS for the Group consolidation.• Project Manager for ERP- JD Edwards implementation in Darrow and PFDC.• Responsible for the study and implementation of the new distribution center in Vitória-ES.• Responsible for the investment study of the new production platform at the plant. Show less

• 

  Coloplast Brasil

  Sept 2010 - Aug 2014

  CFO Brasil

  Spearheaded 15 employees across diverse departments, such as business planning, accounting, tax, finance, legal, logistics, HR, IT, and regulatory affairs. Oversaw critical study and implementation of new distribution center in Itapevi - SP. Directed eight plant inspections conducted by ANVISA in UK, France, US, Denmark, and Hungary. • Accomplished notable 15% annual growth in sales and decreased tax burden by 5% through transfer of distribution center from Rio de Janeiro to São Paulo.• Established new office in São Paulo and led expansion of company and market presence. Show less

• 

  Farmoquimica S/A

  Aug 2014 - Jan 2021

  Diretor Vice-Presidente Financeiro

  Governed team of 101 employees in business planning, accounting, tax, finance, supply, and IT departments. Led reengineering of financial processes and meticulous preparation/analysis of Brazil's monthly management reports. Supervised M&A process, involving four acquisitions and integration of new companies into corporate structure. • Obtained 120M USD loan with International Finance Corporation (IFC) and 40M USD loan with FINEP (Innovation government program).• Achieved 12% annual growth in sales and acquired 15+ high-value companies, products and brands.• Improved product cost efficiency with average margin increases of 1% within year.• Relocated distribution center from Rio de Janeiro to Campina Grande, resulting in 10% tax burden reduction. Show less

• 

  PROTHAID

  Jan 2021 - Aug 2022

  Diretor Executivo - VP

  I acted as a financial advisor across five distinct companies, focusing on Arese Pharma, Advanced Nutrition, Sindi Arese, Mediplast, and Biosani Medical Devices. I streamlined and enhanced processes within finance and administrative departments. I analysed financial data and presented insightful results to shareholders.• Secured a substantial loan of 10M USD for the successful launch of Sindi Arese company through tactical business plans.• Contributed as a key member of the council in reviewing financial results and outlining business initiatives. Show less

• 

  Arese Pharma

  Aug 2022 - now

  Chief Financial Officer

  During this tenure, I oversee a team of 25 professionals across business planning, accounting, tax, finance, HR, supply, and IT departments. I drive process reengineering within Brazil's finance organisation to enhance efficiency and accuracy. I generate monthly management reports, analyse information, and assess key performance indicators to inform strategic decisions. I spearhead the M&A process, guide the company through business development initiatives, and devise a corporate governance process.• Attained 10M USD loan with FINEP (Innovation government program).• Achieved a 20% annual increase in sales through strategic financial leadership and market analysis.• Reduced production costs by 10% in the first year and negotiated with banks to decrease financial costs by 15%, while extending debt terms.• Relocated distribution center from São Paulo to Minas Gerais, resulting in 5% tax burden reduction.• Improved product cost efficiency with average margin increases of 2% within a year.• Prepared the company to receive the first External Audit on 2024.• Expanded product launch strategy from two to eight new products per year, resulting in enhanced market presence and revenue potential. Show less